Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-Apr-24 5:45 PM View:  | Crispr Therapeutics Ag (CRSP) | 15-Apr-24 | Option Exercise | 19,582 | $19.12 | $374,408.00 | 5% 408.12K to 427.7K | |
| 17-Apr-24 5:45 PM View: | Crispr Therapeutics Ag (CRSP) | 15-Apr-24 | Planned Option Sale | 19,582 | $59.91 | $1,173,230.00 | (5%) 427.7K to 408.12K | |
| 18-Mar-24 5:45 PM View: | Crispr Therapeutics Ag (CRSP) | 15-Mar-24 | Option Exercise | 20,000 | $19.12 | $382,400.00 | 5% 408.12K to 428.12K | |
| 18-Mar-24 5:45 PM View: | Crispr Therapeutics Ag (CRSP) | 15-Mar-24 | Planned Option Sale | 20,000 | $72.48 | $1,449,630.00 | (5%) 428.12K to 408.12K | |
| 12-Mar-24 5:45 PM View: | Crispr Therapeutics Ag (CRSP) | 12-Mar-24 | Option Sale | 4,583 | $74.44 | $341,159.00 | (1%) 412.7K to 408.12K | |
| 12-Mar-24 5:45 PM View: | Crispr Therapeutics Ag (CRSP) | 11-Mar-24 | Option Exercise | 9,000 | -- | -- | 2% 413.51K to 422.51K | |
| 12-Mar-24 5:45 PM View: | Crispr Therapeutics Ag (CRSP) | 11-Mar-24 | Option Sale | 9,802 | $78.26 | $767,105.00 | (2%) 422.51K to 412.7K | |
| 12-Mar-24 5:45 PM View: | Crispr Therapeutics Ag (CRSP) | 10-Mar-24 | Option Exercise | 19,250 | -- | -- | 5% 394.26K to 413.51K | |
| 21-Feb-24 5:45 PM View: | Crispr Therapeutics Ag (CRSP) | 20-Feb-24 | Option Sale | 6,370 | $79.67 | $507,498.00 | (2%) 400.63K to 394.26K | |
| 21-Feb-24 5:45 PM View: | Crispr Therapeutics Ag (CRSP) | 18-Feb-24 | Option Exercise | 13,250 | -- | -- | 3% 387.38K to 400.63K | |
| 16-Feb-24 5:45 PM View: | Crispr Therapeutics Ag (CRSP) | 15-Feb-24 | Option Exercise | 20,000 | $19.12 | $382,400.00 | 5% 387.38K to 407.38K | |
| 16-Feb-24 5:45 PM View: | Crispr Therapeutics Ag (CRSP) | 15-Feb-24 | Planned Option Sale | 20,000 | $80.36 | $1,607,180.00 | (5%) 407.38K to 387.38K | |
| 31-Jan-24 5:45 PM View: | Crispr Therapeutics Ag (CRSP) | 29-Jan-24 | Option Exercise | 50,000 | $19.12 | $956,000.00 | 13% 387.38K to 437.38K | |
| 31-Jan-24 5:45 PM View: | Crispr Therapeutics Ag (CRSP) | 29-Jan-24 | Planned Option Sale | 50,000 | $60.51 | $3,025,570.00 | (11%) 437.38K to 387.38K | |
| 18-Jan-24 5:45 PM View: | Crispr Therapeutics Ag (CRSP) | 16-Jan-24 | Option Exercise | 20,000 | $19.12 | $382,400.00 | 5% 387.38K to 407.38K | |
| 18-Jan-24 5:45 PM View: | Crispr Therapeutics Ag (CRSP) | 16-Jan-24 | Planned Option Sale | 20,000 | $62.50 | $1,250,060.00 | (5%) 407.38K to 387.38K | |
| 01-Jun-23 5:44 PM View: | Crispr Therapeutics Ag (CRSP) | 30-May-23 | Option Exercise | 25,000 | $19.12 | $478,000.00 | 6% 387.38K to 412.38K | |
| 01-Jun-23 5:44 PM View: | Crispr Therapeutics Ag (CRSP) | 30-May-23 | Planned Option Sale | 25,000 | $64.88 | $1,621,890.00 | (6%) 412.38K to 387.38K | |
| 27-Apr-23 5:37 PM View: | Crispr Therapeutics Ag (CRSP) | 25-Apr-23 | Option Exercise | 25,000 | $19.12 | $478,000.00 | 6% 387.38K to 412.38K | |
| 27-Apr-23 5:37 PM View: | Crispr Therapeutics Ag (CRSP) | 25-Apr-23 | Planned Option Sale | 25,000 | $50.67 | $1,266,640.00 | (6%) 412.38K to 387.38K | |
| 31-Mar-23 5:49 PM View: | Crispr Therapeutics Ag (CRSP) | 29-Mar-23 | Option Exercise | 25,000 | $19.12 | $478,000.00 | 6% 387.38K to 412.38K | |
| 31-Mar-23 5:49 PM View: | Crispr Therapeutics Ag (CRSP) | 29-Mar-23 | Planned Option Sale | 25,000 | $44.46 | $1,111,500.00 | (6%) 412.38K to 387.38K | |
| 14-Mar-23 5:47 PM View: | Crispr Therapeutics Ag (CRSP) | 13-Mar-23 | Payment of Exercise | 9,444 | $43.22 | $408,170.00 | (2%) 396.82K to 387.38K | |
| 14-Mar-23 5:47 PM View: | Crispr Therapeutics Ag (CRSP) | 11-Mar-23 | Option Exercise | 9,000 | -- | -- | 2% 382.46K to 391.46K | |
| 14-Mar-23 5:47 PM View: | Crispr Therapeutics Ag (CRSP) | 10-Mar-23 | Option Exercise | 11,833 | -- | -- | 3% 375.99K to 387.82K | |
| 01-Mar-23 6:11 PM View: | Crispr Therapeutics Ag (CRSP) | 27-Feb-23 | Option Exercise | 25,000 | $19.12 | $478,000.00 | 7% 375.99K to 400.99K | |
| 01-Mar-23 6:11 PM View: | Crispr Therapeutics Ag (CRSP) | 27-Feb-23 | Planned Option Sale | 25,000 | $48.25 | $1,206,240.00 | (6%) 400.99K to 375.99K | |
| 22-Feb-23 5:38 PM View: | Crispr Therapeutics Ag (CRSP) | 21-Feb-23 | Payment of Exercise | 6,373 | $48.26 | $307,561.00 | (2%) 382.36K to 375.99K | |
| 22-Feb-23 5:38 PM View: | Crispr Therapeutics Ag (CRSP) | 18-Feb-23 | Option Exercise | 13,250 | -- | -- | 4% 369.11K to 382.36K | |
| 31-Jan-23 5:34 PM View: | Crispr Therapeutics Ag (CRSP) | 27-Jan-23 | Option Exercise | 25,000 | $19.12 | $478,000.00 | 7% 369.11K to 394.11K | |
| 31-Jan-23 5:34 PM View: | Crispr Therapeutics Ag (CRSP) | 27-Jan-23 | Planned Option Sale | 25,000 | $51.47 | $1,286,800.00 | (6%) 394.11K to 369.11K | |
| 30-Dec-22 5:33 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Dec-22 | Option Exercise | 25,000 | $19.12 | $478,000.00 | 7% 369.11K to 394.11K | |
| 30-Dec-22 5:33 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Dec-22 | Planned Option Sale | 25,000 | $40.93 | $1,023,290.00 | (6%) 394.11K to 369.11K | |
| 08-Dec-22 5:35 PM View: | Crispr Therapeutics Ag (CRSP) | 06-Dec-22 | Option Exercise | 58,233 | $1.81 | $105,402.00 | 19% 310.88K to 369.11K | |
| 06-Dec-22 5:49 PM View: | Crispr Therapeutics Ag (CRSP) | 05-Dec-22 | Payment of Exercise | 19,401 | $52.26 | $1,013,900.00 | (6%) 330.28K to 310.88K | |
| 06-Dec-22 5:49 PM View: | Crispr Therapeutics Ag (CRSP) | 03-Dec-22 | Option Exercise | 40,000 | -- | -- | 14% 290.28K to 330.28K | |
| 30-Nov-22 5:36 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Nov-22 | Option Exercise | 25,000 | $19.12 | $478,000.00 | 9% 290.28K to 315.28K | |
| 30-Nov-22 5:36 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Nov-22 | Planned Option Sale | 25,000 | $54.03 | $1,350,830.00 | (8%) 315.28K to 290.28K | |
| 28-Oct-22 5:43 PM View: | Crispr Therapeutics Ag (CRSP) | 26-Oct-22 | Option Exercise | 25,000 | $16.84 | $421,016.00 | 9% 290.28K to 315.28K | |
| 28-Oct-22 5:43 PM View: | Crispr Therapeutics Ag (CRSP) | 26-Oct-22 | Planned Option Sale | 25,000 | $54.81 | $1,370,190.00 | (8%) 315.28K to 290.28K | |
| 30-Sep-22 5:42 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Sep-22 | Option Exercise | 25,000 | $16.21 | $405,250.00 | 9% 290.28K to 315.28K | |
| 30-Sep-22 5:42 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Sep-22 | Planned Option Sale | 25,000 | $64.61 | $1,615,160.00 | (8%) 315.28K to 290.28K | |
| 31-Aug-22 5:45 PM View: | Crispr Therapeutics Ag (CRSP) | 29-Aug-22 | Option Exercise | 25,000 | $16.21 | $405,250.00 | 9% 290.28K to 315.28K | |
| 31-Aug-22 5:45 PM View: | Crispr Therapeutics Ag (CRSP) | 29-Aug-22 | Planned Option Sale | 25,000 | $66.84 | $1,671,080.00 | (8%) 315.28K to 290.28K | |
| 29-Jul-22 5:38 PM View: | Crispr Therapeutics Ag (CRSP) | 27-Jul-22 | Option Exercise | 25,000 | $15.00 | $374,918.00 | 9% 290.28K to 315.28K | |
| 29-Jul-22 5:38 PM View: | Crispr Therapeutics Ag (CRSP) | 27-Jul-22 | Planned Option Sale | 25,000 | $75.91 | $1,897,750.00 | (8%) 315.28K to 290.28K | |
| 01-Jul-22 6:00 PM View: | Crispr Therapeutics Ag (CRSP) | 29-Jun-22 | Option Exercise | 25,000 | $12.57 | $314,250.00 | 9% 290.28K to 315.28K | |
| 01-Jul-22 6:00 PM View: | Crispr Therapeutics Ag (CRSP) | 29-Jun-22 | Planned Option Sale | 25,000 | $61.59 | $1,539,860.00 | (8%) 315.28K to 290.28K | |
| 14-Mar-22 6:12 PM View: | Crispr Therapeutics Ag (CRSP) | 14-Mar-22 | Payment of Exercise | 4,153 | $61.08 | $253,665.00 | (1%) 294.43K to 290.28K | |
| 14-Mar-22 6:12 PM View: | Crispr Therapeutics Ag (CRSP) | 11-Mar-22 | Payment of Exercise | 5,487 | $62.56 | $343,267.00 | (2%) 299.92K to 294.43K |